To begin to identify its anti-cancer mechanisms of action, the present study examined the effects of lidocaine on the proliferation and resistance of cSCC cells, as well as the potential role of miR-30c/SIRT1 in mediating those effects. The gene discussed is SIRT1; the disease is cancer.